Stocks and Investing Stocks and Investing
Tue, March 28, 2023
[ 12:00 AM ] - WOPRAI
John Royall Maintained (VLO) at Buy with Increased Target to $172 on, Mar 28th, 2023
[ 12:00 AM ] - WOPRAI
Annabel Samimy Maintained (VKTX) at Strong Buy with Increased Target to $25 on, Mar 28th, 2023
[ 12:00 AM ] - WOPRAI
Jay Olson Maintained (VKTX) at Buy with Increased Target to $30 on, Mar 28th, 2023
[ 12:00 AM ] - WOPRAI
Neal Dingmann Downgraded (WMB) to Hold and Held Target at $31 on, Mar 28th, 2023
[ 12:00 AM ] - WOPRAI
Hans Engel Downgraded (WMT) to Hold on, Mar 28th, 2023
[ 12:00 AM ] - WOPRAI
Steven Zaccone Maintained (WOOF) at Hold with Decreased Target to $8.5 on, Mar 28th, 2023
[ 12:00 AM ] - WOPRAI
Linda Bolton Weiser Reiterated (WW) at Strong Buy and Held Target at $9 on, Mar 28th, 2023
Mon, March 27, 2023
[ 12:00 AM ] - WOPRAI
Joshua Reilly Reiterated (YOU) at Strong Buy and Held Target at $40 on, Mar 27th, 2023
[ 12:00 AM ] - WOPRAI
Heiko Ihle Reiterated (WRN) at Strong Buy and Held Target at $2.75 on, Mar 27th, 2023
[ 12:00 AM ] - WOPRAI
Andy Barish Downgraded (WING) to Sell and Held Target at $160 on, Mar 27th, 2023
[ 12:00 AM ] - WOPRAI
Kate McShane Maintained (WMT) at Strong Buy and Held Target at $55 on, Mar 27th, 2023
[ 12:00 AM ] - WOPRAI
Moshe Katri Maintained (WNS) at Buy with Increased Target to $105 on, Mar 27th, 2023
[ 12:00 AM ] - WOPRAI
Garik Shmois Maintained (WMS) at Strong Buy with Decreased Target to $115 on, Mar 27th, 2023
[ 12:00 AM ] - WOPRAI
Matthew Bouley Maintained (WMS) at Buy and Held Target at $113 on, Mar 27th, 2023
[ 12:00 AM ] - WOPRAI
Sumeet Mody Upgraded (VRTS) to Buy and Increased Target to $260 on, Mar 27th, 2023
[ 12:00 AM ] - WOPRAI
Steve Sakwa Maintained (VNO) at Hold with Decreased Target to $22 on, Mar 27th, 2023
[ 12:00 AM ] - WOPRAI
Hartaj Singh Maintained (VIRX) at Buy with Increased Target to $16 on, Mar 27th, 2023
[ 12:00 AM ] - WOPRAI
Bruno Montanari Maintained (VIST) at Buy with Increased Target to $30 on, Mar 27th, 2023
[ 12:00 AM ] - WOPRAI
Eric Beder Reiterated (VRA) at Strong Buy and Held Target at $9 on, Mar 27th, 2023
[ 12:00 AM ] - WOPRAI
Joe Ritchie Maintained (VNT) at Hold with Increased Target to $28 on, Mar 27th, 2023
[ 12:00 AM ] - WOPRAI
Steve Valiquette Maintained (WBA) at Hold with Decreased Target to $43 on, Mar 27th, 2023
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (VIGL) at Hold with Increased Target to $13 on, Mar 27th, 2023
[ 12:00 AM ] - WOPRAI
Sumeet Mody Upgraded (VCTR) to Buy and Increased Target to $35 on, Mar 27th, 2023
[ 12:00 AM ] - WOPRAI
Mircea Dobre Downgraded (URI) to Sell and Decreased Target to $300 on, Mar 27th, 2023
[ 12:00 AM ] - WOPRAI
John Freeman Maintained (APA) at Strong Buy with Decreased Target to $49 on, Mar 27th, 2023
[ 12:00 AM ] - WOPRAI
Scott Hanold Reiterated (APA) at Hold and Held Target at $54 on, Mar 27th, 2023
[ 12:00 AM ] - WOPRAI
Devin McDermott Maintained (APA) at Hold with Decreased Target to $38 on, Mar 27th, 2023
[ 12:00 AM ] - WOPRAI
Steve Sakwa Maintained (ARE) at Buy with Decreased Target to $144 on, Mar 27th, 2023
[ 12:00 AM ] - WOPRAI
Devin McDermott Maintained (AR) at Hold with Decreased Target to $25 on, Mar 27th, 2023
[ 12:00 AM ] - WOPRAI
Carey Macrury Maintained (APTO) at Strong Buy with Decreased Target to $120 on, Mar 27th, 2023

Carey Macrury Maintained (APTO) at Strong Buy with Decreased Target to $120 on, Mar 27th, 2023


Published on 2024-10-28 02:26:11 - WOPRAI, Carey Macrury
  Print publication without navigation


Carey Macrury of Canaccord Genuity, Maintained "Aptose Biosciences Inc." (APTO) at Strong Buy with Decreased Target from $195 to $120 on, Mar 27th, 2023.

Carey has made no other calls on APTO in the last 4 months.



There is 1 other peer that has a rating on APTO. Out of the 1 peers that are also analyzing APTO, 0 agree with Carey's Rating of Hold.



This is the rating of the analyst that currently disagrees with Carey

  • Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $75 on, Friday, March 24th, 2023
Contributing Sources